Advertisement
TARA Forex-Nachrichten
Protara Reaches Alignment With FDA On A Registrational Path Forward For IV Choline Chloride
Protara Therapeutics, Inc. (TARA) announced Friday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on a registrational path forward for intravenous (IV) Choline Chloride, an investigational phospholipid substrate replacement.
RTTNews
|
vor 524 Tagen
